S-15535

Suppliers

Names

[ Name ]:
S-15535

[Synonym ]:
4-(Benzodioxan-5-yl)-1-(indan-2-yl)piperazine
Piperazine,1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1H-inden-2-yl)
1-(2,3-dihydro-1,4-benzodioxin-8-yl)-4-(2,3-dihydro-1H-inden-2-yl)piperazine
1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1h-inden-2-yl)-piperazine

Chemical & Physical Properties

[ Density]:
1.228g/cm3

[ Boiling Point ]:
504.5ºC at 760mmHg

[ Molecular Formula ]:
C₂₁H₂₄N₂O₂

[ Molecular Weight ]:
336.42700

[ Flash Point ]:
148.9ºC

[ Exact Mass ]:
336.18400

[ PSA ]:
24.94000

[ LogP ]:
2.75010

[ Vapour Pressure ]:
2.63E-10mmHg at 25°C

[ Index of Refraction ]:
1.628

[ Storage condition ]:
2-8℃

Safety Information

[ Symbol ]:

GHS09

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H400

[ Precautionary Statements ]:
P273

[ Personal Protective Equipment ]:
Eyeshields;Gloves

[ Hazard Codes ]:
Xi

[ RIDADR ]:
UN 3077 9 / PGIII

Articles

S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.

J. Pharmacol. Exp. Ther. 282(1) , 132-47, (1997)

The novel, potential anxiolytic, S 15535 (4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine), is an agonist and antagonist (weak partial agonist) at pre- and postsynaptic serotonin (5-HT)1A receptors, resp...

Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.

Br. J. Pharmacol. 132(2) , 518-24, (2001)

1. The interaction of serotonergic ligands at human (h) 5-HT(1A) receptors expressed in Chinese hamster ovary cells was examined with the selective 'neutral' 5-HT(1A) antagonist [(3)H]-WAY100,635. Its...

Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.

J. Med. Chem. 45(1) , 165-76, (2002)

S 15535 (1) displays a distinctive profile of agonist and antagonist (weak partial agonist) activity at pre- and postsynaptic 5-HT(1A) receptors, respectively. It has proven to be active in several mo...